Yingrui Shi
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 10%
- Immune cells in cancer
Papers in
- Oncology 9
- Cancer Cells and Metastasis 3
- Inflammatory Biomarkers in Disease Prognosis 2
-
- Circular RNAs in diseases 2
- Co-authors
- Qianjin Liao (9 shared papers)Linda Oyang (9 shared papers)Longzheng Xia (8 shared papers)Shiming Tan (8 shared papers)Yujuan Zhou (8 shared papers)Jinguan Lin (8 shared papers)Pin Yi (6 shared papers)Shan Rao (6 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (3 papers)Journal of Cancer (2 papers)Journal of Clinical Oncology (2 papers)Molecular Cancer (1 paper)International Immunopharmacology (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Yingrui Shi
24 papers receiving 1.4k citations
Yingrui Shi's Hit Papers
Peers
Comparison fields: 5 of 93
- Cancer Research 487
- Immunology 269
- Oncology 255
- Molecular Biology 620
- Biological Psychiatry 18
Countries citing papers authored by Yingrui Shi
This map shows the geographic impact of Yingrui Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingrui Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingrui Shi more than expected).
Fields of papers citing papers by Yingrui Shi
This network shows the impact of papers produced by Yingrui Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingrui Shi. The network helps show where Yingrui Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yingrui Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The cancer metabolic reprogramming and immune response Hit paper breakdown → | 2021 | 892 |
| 2 | 2020 | 151 | |
| 3 | 2023 | 34 | |
| 4 | 2020 | 33 | |
| 5 | 2024 | 33 | |
| 6 | 2020 | 28 | |
| 7 | 2022 | 21 | |
| 8 | 2021 | 21 | |
| 9 | 2020 | 21 | |
| 10 | 2023 | 19 | |
| 11 | 2014 | 19 | |
| 12 | 2023 | 18 | |
| 13 | Analysis of the correlation among hypertension, the intake of β-blockers, and overall survival outcome in patients undergoing chemoradiotherapy with inoperable stage III non-small cell lung cancer. | 2017 | 15 |
| 14 | 2023 | 14 | |
| 15 | 2019 | 12 | |
| 16 | 2022 | 11 | |
| 17 | 2017 | 11 | |
| 18 | 2024 | 8 | |
| 19 | 2022 | 4 | |
| 20 | 2025 | 2 |
About Yingrui Shi
Yingrui Shi is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Otorhinolaryngology, having authored 24 papers that have together received 1.4k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (3 papers), Cancer Cells and Metastasis (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Circular RNAs in diseases (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Cancer Research (487 citations), Immunology (269 citations), Oncology (255 citations), Molecular Biology (620 citations) and Biological Psychiatry (18 citations). Yingrui Shi has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Qianjin Liao, Linda Oyang, Longzheng Xia, Shiming Tan, Yujuan Zhou, Jinguan Lin, Pin Yi, Shan Rao, Jiaxin Liang and Lu Tang. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Cancer, Journal of Clinical Oncology, Molecular Cancer and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.